Pharmacist-led sedative-hypnotic deprescribing in team-based primary care practice

Abstract

Almost two-thirds of patients participating in our pharmacist-led program were able to stop or taper their SH medications by ≥50%. The role of CBT-I in SH deprescribing remains to be further elucidated. <i>Can Pharm J (Ott)</i> 2021;154:xx-xx.